Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 111
Item hits:
Issue DateTitleAuthor(s)
12-Apr-2017Antacid therapy and disease progression in patients with idiopathic pulmonary fibrosis who received pirfenidoneKreuter, M; Spagnolo, P; Wuyts, W; Renzoni, E; Koschel, D, et al
19-Oct-2018Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practiceFletcher, SV; Jones, MG; Renzoni, EA; Parfrey, H; Hoyles, RK, et al
1-Feb-2017Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosisMolyneaux, PL; Cox, MJ; Wells, AU; Kim, HC; Ji, W, et al
19-Nov-2018Long-term safety of pirfenidone: results of the prospective, observational PASSPORT studyCottin, V; Koschel, D; G√ľnther, A; Albera, C; Azuma, A, et al
28-Apr-2017Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trialVisca, D; Tsipouri, V; Mori, L; Firouzi, A; Fleming, S, et al
14-Apr-2017The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis.Conforti, F; Davies, ER; Calderwood, CJ; Thatcher, TH; Jones, MG, et al
31-Aug-2013The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary FibrosisMolyneaux, PL; Cox, MJ; Willis-Owen, SAG; Mallia, P; Russell, KE, et al
1-Jun-2017The Respiratory Microbiome In Idiopathic Pulmonary FibrosisMolyneaux, PL; Russell, AM; Cox, MJ; Moffatt, MF; Cookson, WO, et al
1-Mar-2017Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis.Fisher, M; Nathan, SD; Hill, C; Marshall, J; Dejonckheere, F, et al
1-Mar-2017Survival in Idiopathic Pulmonary Fibrosis: Perspectives from Pulmonary Arterial Hypertension.Maher, TM; Dejonckheere, F; Nathan, SD